Daily Halftime Update: NVDA gapped up on this morning's session to retest it's ATHs at $152.89 which was tested back in Nov 21, 2024. Looking for a entry between $149.5-$149.95 (Target: $149.73) and a close above $148.98 for confirmation of Continuation to retest those ATHs in the weeks to come. Looking for a $160 Price Target on the Long Trade here.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.